MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/85/0.1/20.12.24 | Delayed Börse Stuttgart 17:24:32 03/06/2024 BST | ||
| 0.33 EUR | +13.79% |
|
| 1 month | +18.37% | ||
| 3 months | +360.32% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 0.33 | +13.79% |
| 31/05/24 | 0.29 | +16.00% |
| 30/05/24 | 0.25 | +2.04% |
| 29/05/24 | 0.245 | -2.00% |
| 28/05/24 | 0.25 | -13.79% |
Delayed Quote Börse Stuttgart
Last update June 03, 2024 at 05:24 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ASTRAZENECA PLC |
| Issuer | Morgan Stanley |
| WKN | MB3KH1 |
| ISIN | DE000MB3KH12 |
| Date issued | 10/02/2023 |
| Strike | 85 $ |
| Maturity | 20/12/2024 (200 Days) |
| Parity | 10 : 1 |
| Emission price | 0.48 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.66 € |
|---|---|
| Lowest since issue | 0.023 € |
| Delta | 0.4x |
| Omega | 8.708 |
| Premium | 12.42x |
| Gearing | 21.62x |
| Moneyness | 0.9276 |
| Difference Strike | 6.05 $ |
| Difference Strike % | +7.12% |
| Spread | 0.01 € |
| Spread % | 2.94% |
| Theoretical value | 0.3350 |
| Implied Volatility | 23.82 % |
| Total Loss Probability | 65.90 % |
| Intrinsic value | 0.000000 |
| Present value | 0.3350 |
| Break even | 88.65 € |
| Theta | -0.01x |
| Vega | 0.02x |
| Rho | 0.01x |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
155.1
USD
Average target price
172
USD
Spread / Average Target
+10.91%
- Stock Market
- Warrants
- Warrant